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ERK pathwayObesity affects over 500 million people worldwide, and has far reaching negative health effects. Given that high
body mass index (BMI) and insulin resistance are associated with alterations in many regions of brain and that
physical activity can decrease obesity, we hypothesized that in Rhesus monkeys (Macaca mulatta) fed a high
fat diet andwho subsequently received reduced calories BMIwould be associatedwith a unique gene expression
signature in motor regions of the brain implicated in neurodegenerative disorders. In the motor cortex with in-
creased BMI we saw the upregulation of genes involved in apoptosis, altered gene expression inmetabolic path-
ways, and the downregulation of pERK1/2 (MAPK1), a protein involved in cellular survival. In the caudate
nucleus with increased BMI we saw the upregulation of known obesity related genes (the insulin receptor
(INSR) and the glucagon-like peptide-2 receptor (GLP2R)), apoptosis related genes, and altered expression of
genes involved in various metabolic processes. These studies suggest that the effects of high BMI on the brain
transcriptome persist regardless of two months of calorie restriction. We hypothesize that active lifestyles
with low BMIs together create a brain homeostasis more conducive to brain resiliency and neuronal survival.
© 2011 Elsevier Inc. All rights reserved.1. Introduction
Since 1980 the number of people worldwide considered obese has
doubled with over 1.5 billion people now considered overweight
(body mass index, BMI, 25 or higher) and 500 million people consid-
ered obese (BMI 30 or higher) [1]. The negative effects of obesity on
health are far reaching. As weight increases to levels deﬁned as over-
weight and obese, the risks for the following conditions also increase:
coronary heart disease, type 2 diabetes, cancers, hypertension, dysli-
pidemia, stroke, liver and gallbladder disease, sleep apnea, osteoar-
thritis, and gynecological problems [2–4]. According to the
American Medical Association the best ways to decrease the risk of
obesity are to eat a diet low in fat and to increase physical activity
levels [5]. Indeed, modern sedentary life is associated with increased
risks for obesity, as well as cardiovascular disease, type II diabetes [6],
and depression [7,8].
In the hypothalamus of the central nervous system (CNS) both in-
sulin and leptin control body weight and feeding behavior. Leptin, a
hormone derived from fat circulating in the blood, informs the, Vanderbilt University, 8130A
A.
irnics).
rights reserved.hypothalamus via JAK/STAT pathway about the energy status of pe-
ripheral tissues [9], and reduces the expression of neuropeptides
(neuropeptide Y (NPY), agouti-related peptide (AgRP), and melano-
cyte stimulating hormone (MSH also known as POMC)) that stimu-
late feeding [9–11]. Insulin, another circulating hormone, serves as a
feedback signal from the periphery to reduce appetite and body
weight in the hypothalamus [12] and serves to cause peripheral tis-
sues to take glucose up from the blood and store it as glycogen [13].
Furthermore, insulin receptors (receptor tyrosine kinases) located
throughout the brain signal through both the PI3K/AKT and ERK1/2
survival signaling pathways [14]. In obesity resistance to leptin and
insulin impairs proper signaling about energy status that results in in-
creased body weight and feeding behaviors. The AKT and ERK1/2 sig-
naling pathways are also downstream of many neurotrophic factor
signaling pathways and activation of these pathways leads to neuro-
protection in several regions of the brain [15,16]. Thus, insulin resis-
tance, may lead to decreased activation of AKT and ERK1/2,
increased apoptosis, and decreased survival of neurons. This could ex-
plain why type II diabetes (insulin resistance) is often linked to Alz-
heimer's disease, a neurodegenerative disorder, and could be even
further detrimental to the total health of the brain [17].
Insulin resistance that results in impaired signaling also affects
other regions of the brain [18]. The effects of insulin on cortical
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gree of peripheral insulin resistance [19]. Furthermore, decreased
brain volumes have been seen in the frontal lobe, the temporal lobe,
the anterior cingulate, the hippocampus, and the basal ganglia with
high BMI [20]. Using correlations of BMI with brain volumes the
same group showed that overweight and obese individual's brains
age prematurely [21]. Other studies also link higher BMI with smaller
regional brain volumes [21–24]. These ﬁndings provide evidence for
cerebral insulin resistance in overweight humans.
Given that high BMI is associatedwith insulin resistance, that insulin
resistance is associated with speciﬁc brain alterations, and that physical
activity can decrease obesity, we hypothesized thatwe could ﬁnd genes
associatedwith BMI inmotor regions of the brain.We investigated tran-
scriptome changes associatedwith BMI in themotor cortex and caudate
nucleus of 14 Rhesus monkeys with DNA microarrays. We found a dis-
tinct BMI associated gene expression signature in both themotor cortex
and the caudate nucleus, and decreased protein phosphorylation of a
survival kinase, pERK1/2, in the motor cortex. Our studies indicate
that obesity is also associated with molecular changes in motor regions
of the brain that these changes include alterations in metabolic and ap-
optotic related genes and that increases in BMI are associated with de-
creases in the phosphorylation of a survival kinase.
The same cohort ofmonkeyswas used in a previous calorie restriction
study, as numerous studies indicate that calorie restriction, like exercise,
is neuroprotective. To mimic the typical American diet Rhesus monkeys
were fed a diet high in fat for the last 3 years of their life. They also under-
went one month of a 30% calorie reduction followed by one month of a
60% calorie reduction at the end of the study [25]. This is typical of a diet-
ing person, and increases the production of BDNF and activates the AKT
and ERK1/2 signaling and survival pathways in the brain [26]. While cal-
orie restriction could theoretically represent a potential confound in our
experiments as it may overcome some of the effects of a high fat diet and
insulin resistance [27], this was not the case: decreased pERK1/2, in-
creased CASP9 & FOXO3mRNA, and an enrichment of apoptosis andme-
tabolism related genes, all indicate decreased neuronal survival,
suggesting that calorie restriction does not overcome the transcriptional
signature of high BMIs in the brain.
2. Results
2.1. Microarray data analysis reveals a BMI-associated gene expression
pattern
We hypothesized that BMI would be associated with a unique
gene expression signature in the motor cortex and caudate nucleus
that may be of importance to neurodegenerative disorders given ob-
served alterations in the brain in insulin resistance. To discover
other alterations we performed whole genome expression proﬁling
of the motor cortex of 14 female, calorie restricted rhesus monkeys
with a wide range of BMIs using both Affymetrix Rhesus Macaque Ge-
nome (RhG) and Human Genome (HG) microarrays (Fig. 1). The rhe-
sus and human genomes share 93% sequence identity [28] and human
microarrays successfully have been used to query rhesus monkey
gene expression changes in the past [29]. Whereas the Affymetrix
RhG microarrays provided us with the most speciﬁc hybridization in-
formation for rhesus monkeys, the Affymetrix HG microarrays con-
tained more extensive and higher quality annotations.
Microarray data were log2 transformed, RMA-normalized [30,31]
and linearly modeled with BMI. We focused on convergent ﬁndings
between the RhG and HG microarrays, which enabled us to identify
a strong and distinct BMI-associated gene expression signature in
the motor cortex and caudate nucleus. Two types of data-mining ap-
proaches were employed. First, we identiﬁed the transcripts that
were associated with BMI, followed by a molecular pathway analysis
that revealed the most affected BMI-associated groups of interdepen-
dent genes.We identiﬁed 27 transcripts that were associated with BMI in the
motor cortex (17 positively correlated and 10 negatively correlated)
and 51 transcripts that were associated with BMI in the caudate nu-
cleus (41 positively correlated and 10 negatively correlated) (Supple-
mentary Table 1 and 2). All altered transcripts in the motor cortex
and in the caudate nucleus were changed in the same direction on
both human and monkey microarrays, suggesting a high degree of
concordance between the two data sets, and a very low false discov-
ery rate in our experiment. Our Pearson Hierarchal Clustering [32]
revealed a progression of gene expression levels from monkeys with
high BMI to monkeys with to low BMI (Fig. 2). Furthermore, we vali-
dated increased expression of caspase 9 (CASP9) in the motor cortex
and increased expression of forkhead box O3 (FOXO3) in the caudate
nucleus with increasing BMI by qPCR (Fig. 3).
Next, we performed Gene Ontology (GO) Biological Process analy-
sis (Supplementary Table 3) using the Gene Ontology Enrichment
Analysis Software Toolkit (GOEAST) [33,34] and GSEA assessment
using the Broad Institute's Gene Pattern Software [35] (Tables 1 and
2) to decipher which biological processes were involved with the
BMI associated gene expression signature. GO Biological Process anal-
ysis searched our differentially expressed gene datasets (Supplemen-
tary Table 1 and 2) for signiﬁcantly altered GO Biological Processes.
While these analyses revealed no signiﬁcant biological processes as-
sociated with signiﬁcant gene expression changes in the motor cor-
tex, in the caudate nucleus we identiﬁed a large number
signiﬁcantly altered biological processes that suggested alteration of
gene networks related to metabolism, cell death, and cellular devel-
opment (Supplementary Table 3).
We also assessed our data for the enrichment of functional gene
pathways using Gene Set Enrichment Analysis (GSEA) [35] using the
gene sets in the Molecular Signatures Database (MSigDBv.3.0) for the
human (HG) arrays. We found 9 gene sets positively enriched with
BMI in the motor cortex (Table 1), and 3 gene sets negatively enriched
with BMI in the caudate nucleus (Table 2). Prominently, in the motor
cortex the BMI-associated changes included VEGFA targets (genes
upregulated in HUVEC endothelium cells at 30 min after VEGFA stimu-
lation [36]) and AKT phosphorylation targets in the cytosol, while in the
caudate nucleus signiﬁcant gene sets included HDAC targets (genes
whose transcription is altered by histone deacetylase inhibitors [37]).
2.2. The observed gene expression changes are putatively a result of
altered ERK1/2 signaling
Several of the BMI-dependent genes attracted further attention.
Our data identiﬁed inversely correlated mRNA levels of forkhead
box O3 (FOXO3) with BMI in the caudate nucleus. FOXO3 is activated
via the growth factor pathway, and involved in apoptosis and neuro-
nal survival [15]. Furthermore, as both AKT and ERK1/2 are effector
signaling pathways of neurotrophic factors [15,16,26,38], we next in-
vestigated the association of the AKT and ERK protein phosphoryla-
tion state with BMI (Fig. 4) through Western analysis. While AKT
levels and its phosphorylation state was unchanged, we identiﬁed a
strong negative correlation of both ERK1/2 and pERK1/2 levels with
BMI (pERK1/2/tubulin r=−0.663 with p=0.010 and pERK1/2/
ERK1/2 of −0.595 with p=0.025) (Fig. 4). As pERK1/2 phosphory-
lates CREB, a transcription factor in the nucleus to reduce apoptosis
[38] and activate transcription of neuronal survival genes [15], the de-
creased phosphorylation of ERK1/2 with increasing BMIs suggests
that this might be a critical signaling pathway mediating some of
the detrimental effects of BMI on the gene expression in the brain.
3. Discussion
In summary, we discovered a distinct gene expression signature
associated with BMI after calorie restriction in the motor cortex and
caudate nucleus. Our linear model allowed us to model BMI and
Fig. 1. Experimental design. Motor cortex and caudate nucleus tissue was harvested from 14 female rhesus macaques with wide ranges of BMI. The motor cortex and caudate nu-
cleus transcriptomes were proﬁled separately using both Affymetrix Rhesus Macaque Genome microarrays (RhG) and Affymetrix Human Genome U133 2.0 Plus microarrays (HG).
We used a linear model to deﬁne gene expression associated with BMI (gene value=α+β (BMI)) for both microarrays separately. Probes were cross matched based on sequence
similarity and signiﬁcance was deﬁned if both microarray models (i) were signiﬁcant with pb0.05, and (ii) had an interquartile range (IQR)>0.263 corresponding to a 20% gene
expression change. Signiﬁcant genes are contained in Supplementary Tables 1 and 2, and clustered in Fig. 2. Pathway analysis was performed using both Gene Ontology (GO) con-
tained in Supplementary Tables 3 and 4, and Gene Set Enrichment Analysis (GSEA) contained in Tables 1 and 2. Note that the human and monkey data are highly concordant for a
set of genes both in the motor cortex and caudate nucleus.
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ture with 100% concordance in directionality between signiﬁcant
probes on RhG and HGmicroarrays. We saw increases in apoptotic re-
lated genes and changes in metabolic related genes across both brain
regions, suggesting that motor regions of the brain are affected at the
transcriptional level by obesity. Decreased ERK1/2 phosphorylation
was associated with increasing BMI. Activation of this prototypical
survival kinase provides a potential explanation for the enrichment
of pro-apoptotic genes in animals with high BMI and putativelyexplains how obesity raises the risk for reduced brain volume
[21–24]. Furthermore, leptin and insulin are both known to activate
ERK1/2 in addition to the AKT pathway [14,39].
Although we did not ﬁnd evidence of BMI-dependent changes to
the AKT signaling pathway, we cannot rule out the possibility of
cross talk between the AKT and ERK1/2 pathways [40–43] in the
non-human primate brain. Furthermore, our previous data suggest
that physical activity is positively correlated with pAKT protein levels
in non-human primates [44], potentially leading to a double-risk to
Fig. 2. Hierarchal clustering of gene expression associated with BMI. Hierarchical clustering was performed on log2-transformed expression level of genes associated with BMI. Ver-
tical column labels indicate BMI in decreasing order. Genes, denoted by Affymetrix Human Probes and NCBI gene symbols, were clustered horizontally. Each colored square rep-
resents a normalized gene expression value with color intensity proportional to magnitude of change (blue indicates a decrease in expression and red an increase). (a) Motor
Cortex Gene Expression Signature for Rhesus Genome Microarrays. (b) Motor Cortex Gene Expression Signature for Human Genome Microarrays. (c) Caudate Nucleus Gene Expres-
sion Signature for Rhesus Genome Microarrays. (d) Caudate Nucleus Gene Expression Signature for Human Genome Microarrays. Note that in both structures there is a progression
of gene expression values from monkeys with low BMI to monkeys with high BMI, and the data are concordant across the human and monkey array platforms.
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increased BMI can repress the activation of the neuronal survival ki-
nase ERK1/2. These two events, in concert might signiﬁcantly in-
crease brain susceptibility to various insults. Although it is tempting
to hypothesize that both of these events are the result of a change
in a growth factor signaling pathway, we found relatively meagerevidence to support this theory at the level of the transcriptome.
However, it is known that growth factor signaling is profoundly reg-
ulated at the post-transcriptional level [16,45] and this should be a
topic of further follow-up experiments.
The positive correlation between the expression of apoptosis-
related genes and BMI is also noteworthy. Increased pro-apoptotic
Fig. 3. Validation of selected microarray-reported changes by qPCR. (a) Body Mass Index
(BMI) was measured in kilograms per crown of rump length squared (kg/CRL2) while
CASP9 and FOXO3 relative expression levels were reported in threshold cycle difference
relative to β-actin and peptidylprolyl isomerase D respectively (ΔCT, dCT). CASP9 and
FOXO3 gene expressions were signiﬁcantly positively correlated with BMI. (b) Scatter
plot showing qPCR expression (1/dCT) versus BMI (CRL2) for CASP9. (c) Scatter plot show-
ing qPCR expression (1/dCT) versus BMI (CRL2) for FOXO3. Note that the microarray-
reported expression changes were successfully validated by qPCR.
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ious environmental insults, and the decreased brain volume observed
in persons with high BMI [21–24] might be closed linked to the gene
expression changes we uncovered.
Since our monkeys were placed on a calorie restriction diet imme-
diately prior to transcriptome analyses some of the deleterious effects
associated with high BMI may have been masked. A number of previ-
ous studies have demonstrated many beneﬁcial effects of calorie re-
striction on health, the rate of aging, and longevity [46]. These
ﬁndings suggest important roles for the plasma membrane redox sys-
tem in protecting brain cells against age-related increases in oxidative
and metabolic stress, and these ﬁndings might be directly related to
the BMI-correlated increases in pro-apoptotic gene expression [47].
Furthermore, our results are in also in concordance with previoustranscriptome proﬁling studies performed on monkeys that under-
went dietary restriction [26]. The neuroprotective effect of dietary re-
striction reported increased production of neurotrophic factors and
protein chaperones, resulting in protection against oxyradical pro-
duction, stabilization of cellular calcium homeostasis, and inhibition
of apoptosis.
Finally, based on our studies and previous literature we conclude
that active lifestyles with low BMI create a brain homeostasis more
conducive to brain resiliency and neuronal survival. Brain health is
clearly linked to body health, and, we now show the converse, that
maintaining a health BMI is also essential for maintaining a healthy
brain transcriptome.
4. Materials and methods
4.1. Subjects
Fourteen adult female ovariectomized rhesus monkeys (Macaca
mulatta) were allowed to eat a high fat diet freely for three years
with care methods previously published [25,48,49]. Their activity
and percent body fat were measured throughout the diet and were
found to be extremely stable. As part of a different study they were
then placed on a two month calorie reduction diet. Food composition
was the same, but their calorie intake was reduced by 30% the ﬁrst
month and 60% the second month from their normal intake. Their
BMI was measured in kilograms/crown of rump length squared (kg/
CRL2) at the end of the study. Monkeys were deeply anesthetized
with ketamine/pentobarbital and their entire brain was removed.
The brain was then hemisected by a midline sagittal cut. The right
hemisphere was cut into 5-mm thick coronal blocks, ﬂash-frozen in
isopentane over dry ice, and stored at −80 °C until use.
4.2. Sample preparation and hybridization
Motor cortex and caudate nucleus brain tissue was homogenized
and total RNA isolated using TRIzol® reagent (Invitrogen, Carlsbad,
CA) with RNA quality assessed via analysis on an Agilent 2100 Bioa-
nalyzer. Only samples with an RIN>7.0 were considered for further
analysis. The samples were prepared using the Enzo BioArray™
Single-Round RNA Ampliﬁcation and Biotin Labeling System. The
samples were primed with a standard T7-oligo(dT) primer and
cDNA synthesis was performed using 2 μg of total RNA according to
the Affymetrix® manufacturer's protocol. Ampliﬁed antisense RNA
(aRNA) was produced using in vitro transcription directed by T7 po-
lymerase. Fifteen micrograms of the puriﬁed and fragmented aRNA
were hybridized to GeneChip® Rhesus Macaque Genome (RhG) Ar-
rays and GeneChip® Human Genome (HG) U133 Plus 2.0 Arrays.
Image segmentation analysis and generation of DAT ﬁles was per-
formed using Microarray Suite 5.0 (MAS5). All data is compliant
with the Minimum Information About a Microarray Experiment
(MIAME) guidelines and raw data is available at ftp://mirnicslab.
vanderbilt.edu/BMI microarrays/.
4.3. Microarray data analysis
Fourteen RhG arrays for the motor cortex and 14 RhG arrays for
the caudate nucleus were scanned and analyzed. Scaling factors ran-
ged from 1.58 to 3.11 with backgrounds from 29.8 to 85 and percent
present calls from 45 to 52%. Fourteen HG arrays for the motor cortex
and 14 HG arrays for the caudate nucleus were scanned and analyzed.
Scaling factors ranged from 6.26 to 15.28, noise was between 1.2 and
1.8, and percent present calls were from 31.3% to 35.0%. Segmented
images were normalized and log2 transformed using robust multi-
array analysis (RMA) separately for Rhesus and Human arrays [50]
with RMA normalized expression levels utilized for all of our subse-
quent analyses.
Table 1
Molecular Signatures Database (MSigDB) signiﬁcant gene sets in the motor cortex using human arrays (HG).
Name Size FDR q-val Enriched genes
Kuninger IGF1 vs. PDGFB targets up 41 0.104 TPM2, CKM, MYBPH, MYOG, RYR1, USP2, MYL1, TNNT2, TNNI1, ENAH,
PYGM, C1QTNF3, PPFIA4, NCAM1, NPNT, SGCA, PKIA, ATP2A1, SMTN
One carbon compound metabolic process 26 0.128 NSUN2, DMAP1, PRMT5, NSD1, CARM1, DNMT3A, DNMT3B, EHMT1, PRM17, FOS, PRMT2
Module 440 18 0.173 CKM, OAT, ASL, GLUD1, BBOX1, CKB, ODC1, ACY1
ABE VEGFA targets 30 min 19 0.179 HDC, DBC1, C2, EGR2, EGR3, CYR61, NR4A1, TRIB1
Schuring STAT5A targets up 7 0.184 LIF, TRAF4, PIM1
Module 199 57 0.197 EPHB6, TEK, IL4R, KIT, KDR, PTK7, EPHB1, TIE1, IL2RB, MERTK, EPHA4, CCL2, MYLK, AXL,
CDK5R1, ERBB2, EPHA7, MAP2K7, PDK4, FGFR3, IL13RA1, IL10RA, ROR2, EFNB3, PDGFRA
Reactome AKT phosphorylates targets in the cytosol 14 0.197 AKT2, CASP9, AKT1, TSC2
S adenosylmethionine dependent methyltransferase activity 22 0.198 METTL1, NSUN2, NSD1, DNMT3A, DNMT3B, EHMT1, PEMT, PRMT7
Methyltransferase activity 34 0.216 ATIC, METTL1, NSUN2, PRMT5, NSD1, CARM1, DNMT3A, DNMT3B, EHMT1,
PBMT, PRMT7, SUV39H1, GART
Table 2
Molecular Signatures Database (MSigDB) signiﬁcant gene sets in the caudate nucleus
on the human arrays (HG). Gene Set Enrichment Analysis (GSEA) was performed on
the caudate nucleus data set. Three gene sets were positively correlated with BMI,
had a nominal p-valueb0.001, and a false discovery rate (FDR)b0.25.
Name Size NOM
p-val
FDR
q-val
Correlation
with BMI
Enriched genes
Cell
maturation
15 0.000 0.137 – TP53, GADD45B, FAS, GSN, CASP3,
GLRX, BAD, CCNE1, TXN, MCM3
Developmental
maturation
17 0.000 0.202 – KCNIP2, MYH11, ACTA1, KRT19,
EREG, IL21, PICK1, MYOZ1
MARKS HDAC
targets up
18 0.000 0.238 – MYH11, ACTA1, KRT19, EREG,
IL21, PICK1, MYOZ1
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We ﬁt data from HG and RhG arrays using the model: log trans-
formed gene expression value=α+β(BMI) [51]. RhG and HG
probe sets were matched on the basis of sequence similarity using
the Affymetrix HG-U133 Plus 2.0 to Rhesus Best Match Spreadsheet.
Genes were considered correlated BMI if (a) pb0.05, where H0:
β=0 for RhG arrays; (b) pb0.05, where H0: β=0 dfor HG arrays;
(c) if the interquartile range, IQR>0.263 on the RhG arrays, measur-
ing the difference between the third and ﬁrst quartiles was less than
0.263 (representing a 20% change in gene expression values); and
(d) if the interquartile range, IQR>0.263 on the HG arrays, measur-
ing the difference between the third and ﬁrst quartiles was less than
0.263 (representing a 20% change in gene expression values). The
strength of our model was tested for false discovery using a binomi-
al probability test for the direction of change, where the H0:
p=0.50. We tested our model using a binomial probability test
with a null hypothesis that p=0.50, which was rejected. Hierarchi-
cal clustering of the replicating data was performed using GenePat-
tern software [32]. Clustering was performed on log2 transformed
GC-RMA normalized expression levels using row (gene) centering
and Pearson correlation.
4.4. Quantitative real-time PCR validation
As previously reported [44,49], we used the High Capacity cDNA
Archive Kit® (Applied Biosystems, Foster City, CA) to synthesize
cDNA from 500 ng of the same total RNA used for microarray analysis
in 11 monkeys. Priming was performed with random hexamers. For
each sample, ampliﬁed product differences were measured with
three independent replicates using SYBR Green chemistry-based de-
tection [30]. β-actin was used as the endogenous reference gene for
caspase 9 (CASP9) and peptidylprolyl isomerase D was used as the
endogenous reference gene for forkhead box O3 (FOXO3). Primer se-
quences for β-actin were 5′ GAT GTG GAT CAG CAA GCA 3′ and 5′
AGA AAG GCT GTA ACG CAA CTA 3′, for CASP9 were 5′ GAG TGG
CTC CTG GTA CGT TG 3′ and 5′ CCT TTC ACC GAA ACA GCA TT 3′, for
peptidylprolyl isomerase D (cyclophilin D, CYC) were 5′ GCA GAC
AAG GTC CCA AAG 3′ and 5′ GAA GTC ACC ACC CTG ACA C 3′, and
for forkhead box O3 (FOXO3) were 5′ GCA TTG TGT GTG TTG CTT
CC 3′ and 5′ CTG AAA TCA CAC CCT GAG CA 3′. The efﬁciency for
each primer set was assessed prior to qPCR measurements, and a
primer set was considered valid if its efﬁciency was >90%. The qPCR
reactions were carried out on an ABI Prism 7300 thermal cycler (Ap-
plied Biosystems Inc.), quantiﬁed using ABI Prism 7300 SDS software
(with the auto baseline and auto threshold detection options select-
ed) and statistically analyzed using Pearson correlations.
4.5. Gene ontology (GO) and gene Set enrichment analysis (GSEA)
We assessed our data for the enrichment of functional gene pathways
using Gene Ontology (GO) Biological Process terms [33,34] and Gene SetEnrichment Analysis (GSEA) [35]. First, we analyzed the GO Biological
Process terms for all of our transcripts signiﬁcantly associated with BMI
in the motor cortex and caudate nucleus using the Gene Ontology En-
richment Analysis Software Toolkit (GOEAST). We reported signiﬁcant
GO biological processes using the hypergeometric test statistic, with a
minimum of 5 genes, and a Benjamini–Yekutieli FDRb0.1 [52]. Second,
we performed GSEA [35] using all of the gene sets in the Molecular Sig-
natures Database (MSigDBv.3.0) for the human (HG) arrays. We report
enriched gene sets with a nominal pvalueb0.01 and a false discovery
rate (FDR)b0.25. Module 199 is most strongly associated with leukemia
and Module 440 is most strongly with associated liver cancer [53].
4.6. Western blots
Infrared imaging of immunoblots was used for assessing phosphor-
ylation and total protein state of ERK1/2 and Akt (Li-Cor Biosciences,
Lincoln, NE). Samples were sonicated in a Triton-based lysis buffer
(Cell Signaling, Danvers, MA) and subjected to standard SDS-page im-
munoblotting procedures. Blots were then blocked in 5% bovine
serum albumin in Tris-buffered saline (TBS) for 1 h prior to incubation
overnight at 4 °C in primary antibody made in the same blocking solu-
tion with 0.1% Tween. Antibodies used were: rabbit anti-phospho-
ERK1/2 (Cell Signaling, Cat. no. 9101), mouse anti-total ERK1/2 (Milli-
pore, Cat. no. 05–1152), rabbit anti-phospho-Akt (Cell Signaling, Cat.
no. 9271), mouse anti-total Akt (Cell Signaling, Cat. no. 2920). Mouse
α-tubulin (Sigma-Aldrich, Cat. no. T5168) was used concurrently to
control for differences in protein loading. After overnight incubation
with primary antibody, blots were washed in TBS-tween and incubated
with goat secondary antibodies raised against the appropriate IgG ﬂuo-
rescing in the infrared range (700 and 800 nm, Li-Cor Biosciences).
After further washing, immunostained protein bands on the blots
were visualized on an Odyssey Infrared Imager and quantiﬁedwith Od-
yssey software (Li-Cor Biosciences).
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